Therapeutic strategies for congenital myasthenic syndromes
To date, more than 25 genes have been implicated in the etiology of the congenital myasthenic syndromes (CMS), and an ever-growing phenotypic landscape is now encountered in the CMS clinic. Unlike the autoimmune form of myasthenia, there is no role for immunomodulatory agents in the treatment of CMS...
मुख्य लेखकों: | Lee, M, Beeson, D, Palace, J |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
Wiley
2018
|
समान संसाधन
-
The congenital myasthenic syndromes.
द्वारा: Palace, J, और अन्य
प्रकाशित: (2008) -
Congenital myasthenic syndromes.
द्वारा: Beeson, D, और अन्य
प्रकाशित: (1997) -
Congenital myasthenic syndromes: an update.
द्वारा: Finlayson, S, और अन्य
प्रकाशित: (2013) -
Congenital myasthenic syndromes and the neuromuscular junction.
द्वारा: Cruz, P, और अन्य
प्रकाशित: (2014) -
The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
द्वारा: Rodríguez Cruz, P, और अन्य
प्रकाशित: (2018)